Position in DTIL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,099,047
+$880,411 QoQ
Shares Held
139,828
+251.8% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 94 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 91%
Shared 9%
None 0%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Derivatives in DTIL
reported options exposure · as of Dec 31, 2020CallValue
$96,743
CallShares
387
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. DTIL ranks #252 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in DTIL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,099,047 | 139,828 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $218,636 | 39,752 | Shares | Defined | 2026-05-15 | |
| 2024-12-31 | $1,151,260 | 302,168 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $146,101 | 16,306 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $153,481 | 15,774 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $180,201 | 493,702 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $161,656 | 474,066 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $87,170 | 165,724 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $87,509 | 116,060 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $98,143 | 82,474 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $232,138 | 178,569 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $521,021 | 325,639 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,512,450 | 1,140,406 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,140,088 | 964,877 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $7,610,249 | 659,467 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,320,604 | 265,224 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $719,127 | 69,481 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $96,743 | 11,600 | Call | Defined | 2021-02-12 | |
| 2020-12-31 | $632,055 | 75,786 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $540,416 | 87,730 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,103,491 | 132,472 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $201,034 | 33,339 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||